-
Jun 10, 2026What Is Molecular Imaging And Why Is It Important in Drug Development?Learn how molecular imaging enables non-invasive visualization of biological processes in vivo and supports translational drug development through longitudinal assessment and bi... -
Jun 05, 2026NHP Radionuclide Biodistribution Studies: Molecular Imaging For Translational...Explore how PET-CT, SPECT, and radionuclide molecular imaging in non-human primates (NHPs) are advancing biodistribution, target engagement, and translational evaluation of anti... -
Jun 02, 2026NHP Heart Failure Model Supports Translational Research On Telomere Restorati...Learn how Prisys Biotechnologies' non-human primate heart failure model contributed to a landmark eBioMedicine study validating telomere restoration gene therapy and advancing c... -
May 29, 2026How DSA And CTA Imaging Improve Cardiovascular Drug Safety EvaluationExplore how DSA and CTA imaging technologies support cardiovascular drug safety evaluation, interventional research, and translational preclinical studies. -
May 27, 2026NHP Arteriovenous Shunt Thrombosis Model in Cynomolgus Monkeys For Translatio...Explore Prisys Biotechnologies’ cynomolgus monkey AV shunt thrombosis model for translational evaluation of anticoagulants, FXI inhibitors, and bleeding risk. -
May 21, 2026Pharmacokinetic Data As A Translational BiomarkerExplore how pharmacokinetic (PK) data function as translational biomarkers in modern drug development, CNS research, biologics, and precision medicine. -
May 15, 2026Non-Human Primate Models Of Pulmonary Fibrosis: Advancing Translational Accur...Explore advanced NHP models for pulmonary fibrosis. Prisys Biotech offers quantitative CT imaging, bronchoscopy-guided dosing, and clinical-grade lung function analysis for biop... -
May 14, 2026Why Drug Development Is Increasingly Dependent On NHP Models | Prisys BiotechDiscover why non-human primate (NHP) models are becoming essential in modern drug development. Learn how NHP pharmacology improves translational research, CNS studies, biologics... -
May 09, 2026PK Data As A Pharmacodynamic Biomarker: Advancing Translational Drug Developm...Discover how pharmacokinetic (PK) data functions as a pharmacodynamic biomarker in modern drug development. Learn how Prisys Biotech supports translational PK/PD research throug... -
Apr 24, 2026Non-GLP Pharmacology Studies For Regulatory Submission: Data Integrity & Labo...Learn how non-GLP pharmacology studies can support regulatory submissions through ALCOA+ data integrity, controlled laboratory practices, and translational NHP models from Prisy... -
Apr 20, 2026Strategic Design Of Nonclinical Pharmacokinetic Studies: From ADME Profiling ...Learn how to design robust nonclinical pharmacokinetic studies, including ADME profiling, dose selection, and sampling strategies. Discover how Prisys Biotech supports translati... -
Apr 17, 2026NHP AV-Shunt Thrombosis Model For Drug Safety Evaluation | Prisys BiotechExplore how Prisys Biotech uses NHP AV-shunt thrombosis and bleeding models to evaluate efficacy and bleeding risk of novel antibody therapeutics targeting coagulation pathways.
